Clincosm LogoSign in Get a demo

Advanced Solid Malignancies

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Malignancies Trial in Irving (GIM122)

Not yet recruiting
  • Advanced Solid Malignancies
  • Irving, Texas
    NEXT Dallas
Sep 8, 2023

Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)

Active, not recruiting
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +1 more
Feb 2, 2023

Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +13 more
Jan 31, 2023

Advanced Solid Malignancies Trial in United Kingdom, United States (CT7001, CT7001 in combination with fulvestrant, CT7001 (in

Completed
  • Advanced Solid Malignancies
  • CT7001
  • CT7001 in combination with fulvestrant
  • Tucson, Arizona
  • +22 more
Jan 26, 2023

Advanced Solid Malignancies Trial in Tbilisi, Chisinau, Cluj-Napoca (AZD5305, Itraconazole)

Recruiting
  • Advanced Solid Malignancies
  • Tbilisi, Georgia
  • +2 more
Jan 20, 2023

Advanced Solid Malignancies Trial in Worldwide (AZD9574, Temozolomide)

Recruiting
  • Advanced Solid Malignancies
  • La Jolla, California
  • +30 more
Dec 20, 2022

Advanced Solid Malignancies Trial in Worldwide (MEDI4736 (Durvalumab), MEDI4736 (Durvalumab) + Tremelimumab)

Active, not recruiting
Has Results
  • Advanced Solid Malignancies
  • MEDI4736 (Durvalumab)
  • MEDI4736 (Durvalumab) + Tremelimumab
  • Santa Rosa, California
  • +78 more
Aug 18, 2022

Advanced Solid Tumor, Advanced Solid Malignancies Trial in United States (PRJ1-3024)

Recruiting
  • Advanced Solid Tumor
  • Advanced Solid Malignancies
  • Denver, Colorado
  • +4 more
Aug 9, 2022

Advanced Solid Malignancies Trial in Kogarah, Macquarie, Frankston (YH002)

Completed
  • Advanced Solid Malignancies
  • Kogarah, New South Wales, Australia
  • +2 more
Jul 21, 2022

Advanced Solid Malignancies Trial in Chuo-ku (Ceralasertib)

Recruiting
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
    Research Site
Jul 20, 2022

Advanced Solid Tumor, Advanced Solid Malignancies Trial in China (PRJ1-3024)

Recruiting
  • Advanced Solid Tumor
  • Advanced Solid Malignancies
  • Zhengzhou, Henan, China
  • +4 more
Jul 12, 2022

Advanced Solid Malignancies Trial in Taipei (OB318 capsule)

Recruiting
  • Advanced Solid Malignancies
  • OB318 capsule
  • Taipei, Taiwan
  • +1 more
Nov 12, 2021

Advanced Solid Malignancies Trial in Phoenix, Jacksonville, Rochester (PT01 (Pegtomarginase))

Recruiting
  • Advanced Solid Malignancies
  • PT01 (Pegtomarginase)
  • Phoenix, Arizona
  • +2 more
Aug 10, 2021

Advanced Solid Malignancies Trial in Amsterdam (TKI258)

Completed
  • Advanced Solid Malignancies
  • Amsterdam, Netherlands
    Novartis Investigative Site
Dec 17, 2020

Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD4635)

Completed
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +1 more
Dec 7, 2020

Advanced Solid Malignancies Trial in Toronto, Toulouse Cedex 3, Barcelona (HSP990)

Completed
  • Advanced Solid Malignancies
  • Toronto, Ontario, Canada
  • +2 more
Dec 6, 2020

Advanced Solid Malignancies Trial in Spain, United States (MLN0128)

Completed
Has Results
  • Advanced Solid Malignancies
  • Scottsdale, Arizona
  • +15 more
Mar 18, 2020

Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,

Completed
Has Results
  • Advanced Solid Malignancies
  • Hematologic Malignancies
  • Fort Myers, Florida
  • +2 more
Jun 28, 2019

Advanced Solid Malignancies, Malignant Lymphomas Trial in Tainan, Taipei (Gemcitabine HCl Oral Formulation)

Completed
  • Advanced Solid Malignancies
  • Malignant Lymphomas
  • Gemcitabine HCl Oral Formulation
  • Tainan, Taiwan
  • +2 more
Jul 3, 2019

Advanced Solid Malignancies Trial in Chuo-ku (MEDI9447 (oleclumab))

Completed
  • Advanced Solid Malignancies
  • MEDI9447 (oleclumab)
  • Chuo-ku, Japan
    Research Site
Jul 4, 2019

Advanced Solid Malignancies Trial in Kashiwa, Matsuyama-shi (AZD9150, Durvalumab)

Completed
  • Advanced Solid Malignancies
  • AZD9150, Durvalumab
  • Kashiwa, Japan
  • +1 more
Jun 21, 2019

NSCLC, Advanced Solid Malignancies Trial in Edmonton (Theophylline, Erlotinib)

Terminated
  • Non-small Cell Lung Cancer
  • Advanced Solid Malignancies
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
May 1, 2019

Advanced Solid Malignancies Trial in Taipei (MPT0E028)

Completed
  • Advanced Solid Malignancies
  • Taipei, Taiwan
  • +1 more
Apr 9, 2019

Cancer, Advanced Solid Malignancies Trial in Worldwide (AZD4547)

Terminated
Has Results
  • Cancer
  • Advanced Solid Malignancies
  • Stanford, California
  • +28 more
Nov 30, 2018

Cancer, Advanced Solid Malignancies Trial in Chuo-ku, Fukuoka-shi, Sapporo-shi (olaparib)

Completed
Has Results
  • Cancer
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +2 more
Dec 15, 2017